Full Press Release Details
Adjourns Annual General Meeting
September 4, 6:45 am ET
Sept. 4 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA - News), a leading
provider of vaccines in China, today announced that its Annual General Meeting
originally scheduled for September 4, 2008 has been adjourned to September 18,
September 4, 2008 Annual General Meeting, the required quorum of a majority of
the outstanding shares was not present. In accordance with Antigua law, the
meeting is adjourned to September 18, 2008 (the same day two weeks after
September 4), at 9 a.m. Beijing time at Sinovac's headquarters located at No.
39, Shangdi Xi Rd., Haidian District, Beijing, PRC (the same time and place as
the originally scheduled meeting). Under Antigua law and in compliance with
American Stock Exchange requirements, if a quorum is not present within thirty
minutes of the appointed time for holding the adjourned meeting, the
shareholders then present representing at least one-third of the total
outstanding shares will constitute a quorum.
Biotech Ltd. is a China-based biopharmaceutical company that focuses on the
research, development, manufacture and commercialization of vaccines that
protect against human infectious diseases. Sinovac's commercialized vaccines
include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu
(influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal
Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional
information about Sinovac is available on its website, http://www.sinovac.com
. To be added to our distribution list, please email: info@sinovac.com.
announcement contains forward-looking statements. These statements are made
under the "safe harbor" provisions of the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be identified by words
or phrases such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements. Among other things, the
business outlook and quotations from management in this press release contain
forward-looking statements. Statements that are not historical facts, including
statements about Sinovac's beliefs and expectations, are forward-looking
statements. Forward-looking statements involve inherent risks and uncertainties.
A number of important factors could cause actual results to differ materially
from those contained in any forward- looking statement. Sinovac does not
undertake any obligation to update any forward-looking statement, except as
required under applicable law.
more information, please contact:
Tel: +86-10-8289-9871
Fax: +86-10-6296-6910
Carrington/Janine McCargo
Tel: +1-646-536-7017/7033